• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, February 6, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Trapping female mosquitoes helps curb chikungunya virus

Bioengineer by Bioengineer
July 25, 2019
in Immunology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Tyler M. Sharp (CC BY 4.0)

The U.S. Centers for Disease Control and Prevention (CDC) recently developed an Autocidal Gravid Ovitrap (AGP trap) that attracts and captures female mosquitos looking for a site to lay eggs. Now, researchers writing in PLOS Neglected Tropical Diseases report that AGO traps successfully protected people from infection with chikungunya virus (CHIKV) in communities in Puerto Rico.

The lack of effective tools to control Aedes aegypti mosquito populations has resulted in the continued expansion of dengue virus, Zika virus and CHIKV. Some recent attempts at curbing mosquito populations have resulted in reductions in mosquito density but not reductions in human disease. AGO traps consist of a pail with hay and water to attract egg-bearing female mosquitos and a sticky lining to which the insects adhere. Previous studies have shown that placing three AGO traps outside of 85% of homes in a community resulted in an 80% reduction in adult mosquito populations but the studies did not assess rates of mosquito-borne diseases in humans.

In the new work, Tyler Sharp, of the CDC, and colleagues randomly selected 290 households in Puerto Rican communities that had AGO trap interventions and 349 households in communities without AGO traps. 175 household members from intervention communities and 152 from non-intervention communities were enrolled in the study. Blood samples were collected from each participant to detect CHIKV infection and surveys recorded demographic information as well as data on mosquito repellant and bed net use and frequency of mosquito bites.

A total of 114 participants (34.9%) were seropositive for CHIKV. Among people who spent most of their daytime hours inside the community they lived in, 10.3% were seropositive for CHIKV in communities with AGO traps whereas 48.7% were positive for CHIKV in communities without traps. Among all participants, including those who did not spend as much daylight time within the community, 26.1% were seropositive for CHIKV in the intervention communities and 43.8% were positive in communities without traps.

“AGO traps are a novel chemical-free, effective approach to control Ae. aegypti populations and provide protection from infection with the pathogens that these mosquitos transmit,” the researchers say. “Further evaluations should determine if AGO traps are sustainable and effective in larger scale community trials.”

###

Citation: Sharp TM, Lorenzi O, Torres-Velásquez B, Acevedo V, Pérez-Padilla J, et al. (2019) Autocidal gravid ovitraps protect humans from chikungunya virus infection by reducing Aedes aegypti mosquito populations. PLOS Neglected Tropical Diseases 13(7): e0007538. https://doi.org/10.1371/journal.pntd.0007538

Funding: The authors received no specific funding for this work.

Competing Interests: The authors have declared that no competing interests exist. Autocidal gravid ovitraps (AGO traps) used in this study were developed and constructed by CDC personnel (RB). Rights for the AGO trap patent (US 9.237,741
B2) were transferred to the US Government (Executive Order 10096). Eventual royalties derived from trap sales by licensed companies follow 15 U.S.C. 3710c.

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd. 0007538

Media Contact
PLOS Neglected Tropical Diseases
[email protected]

Related Journal Article

http://dx.doi.org/10.1371/journal.pntd.0007538

Tags: BiologyDeveloping CountriesEcology/EnvironmentEnvironmental HealthEpidemiologyHealth Care Systems/ServicesInfectious/Emerging DiseasesMedicine/HealthParasitologyVirology
Share13Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

$1.6M gift to Markey Cancer Center will establish endowed chair in gynecologic oncology

VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Scientists pinpoint protein that helps cancer-causing viruses evade immune response

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In